Related Experiment Video

Updated: Jun 20, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

[Disturbances of primary hemostasis in patients with dilation cardiomyopathy]

A B Sumarokov, L I Buriachkovskaia, I A Uchitel'

    Kardiologiia
    |September 24, 2009
    PubMed

    Insights

    Platelet activity and aggregation were studied in patients with dilation cardiomyopathy. Findings indicate heightened platelet activity and circulating leukocyte-platelet aggregates, suggesting inflammation and potential viral involvement in disease progression.

    Area of Science:

    • Cardiology
    • Hematology
    • Pathology

    Background:

    • Dilation cardiomyopathy is a complex cardiac condition.
    • Platelet function and morphology may play a role in its pathogenesis.
    • Inflammatory processes and rheological disturbances are implicated in cardiovascular diseases.

    Purpose of the Study:

    • To investigate platelet morphological characteristics and aggregation parameters in patients with dilation cardiomyopathy.
    • To explore the presence of circulating leukocyte-platelet aggregates.
    • To identify potential viral involvement within platelets.

    Main Methods:

    • Morphological analysis of platelets.
    • Assessment of platelet aggregation.
    • Detection of circulating leukocyte-platelet aggregates.
    • Virusological examination of platelets.

    Main Results:

    • Significantly augmented platelet aggregatory activity was observed in 76% of patients.
    • Circulating leukocyte-platelet aggregates were prevalent, indicating an inflammatory process.
    • Viral presence within platelets was detected in two patients, suggesting a potential mechanism for disease spread.

    Conclusions:

    • Patients with dilation cardiomyopathy exhibit heightened platelet activity and aggregation.
    • Leukocyte-platelet aggregates suggest an ongoing inflammatory state and potential blood flow disturbances.
    • Intraplatelet viral presence represents a novel potential pathway for viral dissemination and disease progression in dilation cardiomyopathy.

    More Related Videos

    Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

    Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

    Published on: February 11, 2022

    Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine12:37

    Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

    Published on: February 9, 2016

    Related Concept Videos

    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Disorders of Hemostasis01:24

    Disorders of Hemostasis

    Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
    Thromboembolic Disorders
    Two factors primarily cause thromboembolic conditions.
    Imbalances in Cardiac Output01:26

    Imbalances in Cardiac Output

    The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
    CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...